About Us
The Genomic Medicine Institute is committed to performing translational and clinical human genetics and genomics investigation and fostering innovation toward realizing the benefits of personalized genomic-based healthcare.
More About Us
Featured Lab
Feixiong Cheng Lab
The Cheng lab develops and utilizes innovation network medicine methodologies and systems biology technologies to predict drug targets and identify mechanisms of human diseases.
Learn More
Featured Lab
Mihriban Karaayvaz Lab
The Karaayvaz lab focuses on understanding early events in breast cancer with the goal of identifying individualized therapeutic vulnerabilities.
Learn More
Featured Lab
Ignacio Mata Lab
Dr. Mata's lab studies the genes involved in neurological disorders, such as Parkinson's disease, with a significant focus on underrepresented populations. Dr. Mata also coordinates the Latin American Research Consortium on the Genetics of Parkinson’s disease.
Learn MoreResearch News & More
Sharing genomic data for more than 100,000 colorectal cancer cases helps researchers discover 155 high-confidence genes linked to disease risk.
The open-source artificial intelligence (AI) technology uses human genetic data to identify candidate drugs.
Analyzing data from more than 5 million patients revealed telmisartan is associated with lower Alzheimer’s disease incidence in Black patients, providing clues for potential treatment and prevention.